Satellos Bioscience Inc.
MSLE | NASDAQ
$6.70
-$0.12 (-1.69%)
At close: Oct 30, 2026, 4:00 PM ET
$6.82
+$0.12 (+1.79%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Market Data
Market Cap $8.63M
Enterprise Value $-53.13M
Beta 1.17
Average Volume 55.27K
Shares Outstanding (Diluted) 20.83M
Shares Change YoY 45.99%
Institutional Ownership 36.89%
Exchange NASDAQ
ISIN CA80401L8033
Price Performance
Price Change 1M -21.2%
Price Change 3M -32.9%
Price Change 6M -14.7%
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -28.1%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR -6.7%
Valuation
PE Ratio -3.49
Forward PE N/A
PEG Ratio -0.69
Forward PEG -0.04
PS Ratio N/A
Forward PS N/A
PB Ratio 0.14
P/FCF Ratio -0.30
P/Adj. FCF Ratio -0.28
P/OCF Ratio -4.86
EV/Sales N/A
EV/EBIT 1.50
EV/EBITDA 1.50
EV/FCF 1.85
Earnings Yield -28.7%
FCF Yield -332.2%
Adj. FCF Yield -352.6%
Financial Health
Net Cash $61.76M
Total Debt $0
Cash & Short-Term Investments $61.76M
Total Assets $65.69M
Current Ratio 11.22
Quick Ratio 11.22
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -1.99
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -6.1%
Returns
Return on Assets -53.2%
Return on Equity -72.7%
Return on Invested Capital -60.1%
Return on Capital Employed -60.1%
Return on Tangible Assets -53.2%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 11.8%
EPS CAGR 5Y 35.6%
EPS CAGR 10Y -15.0%
FCF CAGR 3Y -12.8%
FCF CAGR 5Y -31.2%
FCF CAGR 10Y -30.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y 5.0%
Revenue Growth Next 3Y N/A
Earnings Date Nov 13, 2026
EPS Estimate (next Q) -$0.60
EPS Growth Est (next Q) 64.4%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $20.00
Price Target Upside 198.5%
Cash Flow
Operating Cash Flow $-28.67M
Free Cash Flow $-28.68M
Adj. Free Cash Flow $-30.44M
FCF Per Share -$1.38
OCF Per Share -$1.38
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-3.97K
Operating Income $-35.51M
EBITDA $-35.51M
Net Income $-34.31M
EPS (Diluted) -$1.92
Revenue / Employee N/A
Profit / Employee $-1.91M
Employees 18
Add to Watchlist
Select watchlists to add or remove MSLE